ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Scientists Have Discovered a New Stem Cell That Could Heal Brain Damage – ScienceAlert

Scientists Have Discovered a New Stem Cell That Could Heal Brain DamageScienceAlert"The brain is not good at repairing itself, but these newly-discovered stem cells suggest there may be a way to improve its ability," says one of the researche… Continue reading

2018-04-07 Michael Zand NEWS

Health Beat: Fighting Parkinson’s with shrimp, CRISPR – WFMZ Allentown

Continue reading

2018-04-06 Michael Zand NEWS

Health Beat: Fighting Parkinson’s with shrimp, CRISPR – WFMZ Allentown


WFMZ Allentown

Health Beat: Fighting Parkinson’s with shrimp, CRISPR
WFMZ Allentown
ORLANDO, Fla. – One million Americans are living with Parkinson’s disease, and for many, current medications don’t always control the side-effects and tremors. “They’ve affected me since I was in my 30s,” said Harriet Marksfield. “Sometimes you get so …
YOUR HEALTH: Using seafood to fight Parkinson’s?WQAD.com

all 12 news articles »

Continue reading

2018-04-06 Michael Zand NEWS

Targeting Survivin May Open New Avenues for Immunotherapy – Cancer Network

Targeting Survivin May Open New Avenues for ImmunotherapyCancer Network… including many glioma, lung, pancreatic, breast, and neuroendocrine tumors, as well as some forms of multiple myeloma, lymphoma, and leukemia. Fenstermaker said since survivin i… Continue reading

2018-04-06 Michael Zand NEWS

Targeting Survivin May Open New Avenues for Immunotherapy – Cancer Network

Targeting Survivin May Open New Avenues for ImmunotherapyCancer Network… including many glioma, lung, pancreatic, breast, and neuroendocrine tumors, as well as some forms of multiple myeloma, lymphoma, and leukemia. Fenstermaker said since survivin i… Continue reading

2018-04-06 Michael Zand NEWS

Dr. McGregor on Immunotherapy Combinations in Kidney Cancer – OncLive

OncLiveDr. McGregor on Immunotherapy Combinations in Kidney CancerOncLiveBradley McGregor, MD, physician, Genitourinary Oncology program, Dana-Farber Cancer Institute, instructor of medicine, Harvard Medical School, discusses combinations of immunother… Continue reading

2018-04-06 Michael Zand NEWS

Gene therapy improves daylight vision, color vision deficiencies in animal model – Santa Rosa Press Gazette

Santa Rosa Press GazetteGene therapy improves daylight vision, color vision deficiencies in animal modelSanta Rosa Press GazetteNow, University of Florida Health researchers have found a gene therapy that restored crucial visual functions to affected c… Continue reading

2018-04-06 Michael Zand NEWS

Incyte-Merck trial failure deals a blow to cancer immunotherapy, but researchers remain hopeful – CNBC


WFMZ Allentown

Health Beat: Fighting Parkinson’s with shrimp, CRISPR
WFMZ Allentown
ORLANDO, Fla. – One million Americans are living with Parkinson’s disease, and for many, current medications don’t always control the side-effects and tremors. “They’ve affected me since I was in my 30s,” said Harriet Marksfield. “Sometimes you get so …
YOUR HEALTH: Using seafood to fight Parkinson’s?WQAD.com

all 12 news articles »

Continue reading

2018-04-06 Michael Zand NEWS
  • 1
  • …
  • 286
  • 287
  • 288
  • 289
  • 290
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

CNBC

Incyte-Merck trial failure deals a blow to cancer immunotherapy, but researchers remain hopeful
CNBC
The future of cancer immunotherapy looks promising, but it suffered a major setback on Friday. Incyte announced that its trial drug epacadostat did not help melanoma patients, and the company is halting the study altogether. Epacadostat was supposed to …
Melanoma trial failure deals heavy blow to immunotherapy hopesFinancial Times
Incyte stock drops after melanoma therapy drug testing failsThe News Journal
Incyte Shares Tumble After Cancer Drug Fails in Trial With Merck’s KeytrudaWall Street Journal
Markets Insider –STAT
all 201 news articles »